An interventional study of Cognitive Behavioural Therapy in Depression and Quality of Life, sponsored by Linkoeping University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-27.
Sponsored by Linkoeping University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies in Depression by Linkoeping University — 4 open to participants now, 7 under way, none of them phase 3. Depression · Linkoeping University.
Among the 29 studies in Depression by Linkoeping University, this one is the 8th largest by planned enrollment of the 27 interventional ones that give a count, is the only one that started in 2022, is one of 26 with no phase, and was the 20th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →4 of the 29 studies in Depression by Linkoeping University are open now, in 1 country. Recruiting first, the newest first:
Linkoeping University · Sites in Sweden
Ages 18+
Linkoeping University · Sites in Sweden
Ages 18+
Linkoeping University · Sites in Sweden
Ages 18+
By country, each count listing its studies:
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2022.
This study's planned enrollment of 120 is above the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 81 across the 27 interventional studies, 27 across the 2 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Linkoeping University is the lead sponsor of 193 studies on the registry; 40 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 29 studies in Depression by Linkoeping University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The study seeks to investigate the effects of a guided internet-based cognitive behavioral therapy (ICBT) programme on adult mental health problems related to the climate crisis. ICBT will be compared to a wait-list control group.
Participants will be recruited in Sweden with a nationwide recruitment.
The study is set up as a randomized controlled trial. Quality of life, depressive symptoms, anxiety, sleep problems and traumatic stress will be measured. Given uncertainties regarding the psychological effects connected to the climate crisis, a transproblematic tailored treatment approach will be used that has been tested in several previous trials. However, the present program has been adapted for the target population of people who are affected directly or indirectly by the societal and individual consequences of the climate crisis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Experience mental health problems that are caused or exacerbated by the climate crisis and/or its consequences 18 years or older. Adequate ability to understand and speak Swedish. Access to the internet and a smartphone/computer.
Exclusion Criteria:
Other ongoing psychological treatment or counselling that interfere with trial treatment.
Recent (within the past 3 months) changes in the dose of psychotropic medication.
Any severe psychiatric or somatic conditions that would interfere with trial treatment
ICBT, were participants receive 8 out of 15 possible modules, depending on their current problems and needs, 8 week long internet intervention for coping with mental health issues related to the climate crisis.
Behavioral: Cognitive Behavioural Therapy
Participants in the control group will be instructed to wait. Once intervention group will be finished, participants in control group will be able to access the same intervention.
Intervention based on cognitive behavioural therapy principles and adapted to mental health problems related to the climate crisis. Intervention's main purpose is to increase management of mental health issues such as depressive symtoms, stress, worry and anxiety related to the coronavirus pandemic and increase quality of life in the current situation. Intervention contains psycho-educational elements as well as examples and exercises.
Change in Becks Depression Inventory-II
Measure of depressive symptoms. Possible range for the total sum: 0 to 63 (created by summing up the score from each item) with a higher score indicating a higher level of depressive symptoms. Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 13-19, 20-28, and 29-63 points.
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination
Change in Perceived Stress Scale
It is a measure of the degree to which situations in one's life are appraised as stressful. It contains 10 items that are scored on a range between 0 (never) to 4 (very often). The total score can range from 0-56 and a higher score reflects higher levels of perceived stress.
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.
Change in Generalised Anxiety Disorder 7-item scale
Seven item measure of generalized anxiety disorder. Sum score range from 0 to 21, with higher scores indicating more generalized anxiety. Cut-offs for interpretation: 0-5 minimal anxiety, 6-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.
Change in Insomnia Severity Index
Measure of insomnia severity and symptoms of disordered sleep. The total score can range between 0 (no sleep problems) to 28 (severe sleep problems and insomnia) with higher scores indicating severer levels of sleeping problems. Norm score ranges include low likelihood of sleep problems (0 to 7 points), some sleep problems (8 to 14 points), moderate sleep problems (15 to 21 points), severe sleep problems (22 to 28 points).
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.
Change in Patient Health Questionnaire
Measure of depressive symptoms. Possible range for the total sum: 0 to 27 (created by summing up the score from each item) with a higher score indicating higher levels of depression. Clinical cut-offs for mild, moderate, moderately severe and severe major depressive disorder are considered to be 5, 10, 15, and 20 points.
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.
Change in Alcohol Use Disorder Identification Test
The Alcohol Use Disorders Identification Test is a 10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. 10 items and scores ranging from 0-40 with higher scores indicating a higher level of alcohol use.
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.
Change in ClimateCope Index (CCI)
This scale was constructed by the research group, measuring coping strategies connected to the climate situations. It is a 33 item scale rating from 1 (not at all) to 5 (totally agree), with higher scores indicating more helpful coping strategies.
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination
Change in Brunnsviken Brief Quality of Life Scale
Measure of quality of life, total score ranging from 0 to 96 with a higher score indicating a higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied with the score of an item measuring the perceived importance of the area in question.
Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination
Started Feb 2022 (actual). Primary completion is estimated for Jun 2024, 28 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 28 months is above that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.